{"count": 1, "results": [{"_id": "29263150", "pmid": 29263150, "title": "Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).", "journal": "Circulation", "authors": ["Giugliano RP", "Cannon CP", "Blazing MA", "Nicolau JC", "Corbalán R", "Špinar J", "Park JG", "White JA", "Bohula EA", "Braunwald E", "IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) Investigators"], "date": "2018-04-10T00:00:00Z", "doi": "10.1161/CIRCULATIONAHA.117.030950", "meta_date_publication": "2018 Apr 10", "meta_volume": "137", "meta_issue": "15", "meta_pages": "1571-1582", "score": 50057.137, "text_hl": "In contrast, among @SPECIES_9606 @@@patients@@@ without @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@DM@@@, those with a high risk score experienced a significant (18%) relative reduction in the composite of @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular death@@@, @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@, and @<m>DISEASE_Cerebral_Infarction</m> @DISEASE_MESH:D002544 @@@ischemic stroke@@@ with @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@E/S@@@ compared with placebo/@CHEMICAL_Simvastatin @CHEMICAL_MESH:D019821 @@@simvastatin@@@, whereas @SPECIES_9606 @@@patients@@@ without @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@DM@@@ at low or moderate risk demonstrated no benefit with the addition of @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ to @CHEMICAL_Simvastatin @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (Pint =0.034). ", "citations": {"NLM": "Giugliano RP, Cannon CP, Blazing MA, Nicolau JC, Corbalán R, Špinar J, Park JG, White JA, Bohula EA, Braunwald E, IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) Investigators. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation. 2018 Apr 10;137(15):1571-1582. PMID: 29263150", "BibTeX": "@article{29263150, title={Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).}, author={Giugliano RP and Cannon CP and Blazing MA and Nicolau JC and Corbalán R and Špinar J and Park JG and White JA and Bohula EA and Braunwald E and IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) Investigators}, journal={Circulation}, volume={137}, number={15}, pages={1571-1582}}"}}]}